Recent work has shown that treatment of colorectal cancer cells and breast cancer cells and tissues with a novel AMPK activator (FNDs) induces apoptosis and cancer cell death (Kenlan et al., 2017; Johnson et al., 2019). Here, PRKAA2 is linked to cancer.